Sort by
Refine Your Search
-
which must be in advanced courses. Alternatively, you have gained essentially corresponding knowledge in another way. Applicants are expected to hold a Biomedical Laboratory Science degree (Biomedicinsk
-
knowledge in another way. Applicants are expected to hold a three-year Bachelor’s degree in Biomedical Laboratory Science and at least one-year Master’s degree corresponding to 60 higher education credits
-
science. At Umeå University, the initiative includes two PhD positions for candidates with a background in biomedical laboratory science who have complemented their undergraduate education with a master’s
-
of peptidomics. The research group is based at the Biomedical Centre (BMC), Division of Dermatology and Venereology, Department of Clinical Sciences Lund, Lund University, and conducts translational research
-
) . The group is located in the Division of Cell and Neurobiology (CNB) , at the Department of Biomedical and Clinical Sciences (BKV) , Linköping. The research group focuses on integrative multi-omics
-
) . The group is located in the Division of Cell and Neurobiology (CNB) , at the Department of Biomedical and Clinical Sciences (BKV) , Linköping. The research group focuses on integrative multi-omics
-
, control theory, and applied mathematics, spanning diverse application domains such as medicine, energy systems, biomedical systems, neuroscience, and safety and security. The Division of Systems and Control
-
cerebellar function and motor learning. The group is led by Associate Professor Anders Rasmussen and is located at the Biomedical Center in Lund. The research group includes both scientific and technical staff
-
Description of the Workplace The PhD project will be conducted within the field of peptidomics. The research group is based at the Biomedical Centre (BMC), Division of Dermatology and Venereology
-
) at Uppsala University and SciLifeLab , the national infrastructure for life science. Project description Immunotherapy has become a life-saving option for advanced cancer patients. However, only a minority of